The key steps in this approach are (1) extraction of exosomes (HER2 positive/negative) from breast cancer patients and (2) subsequent capture by the aptameric HER2 region of the capture probe anchored to the chip surface, and exposing the G4 DNA sequence (3). Here, ERBB2 is linked to breast cancer.